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Abstract The exposure of Epstein-Barr virus immortalised B
cells (LCLs) to the genotoxic effects of gamma irradiation
causes a decreased proliferation of the cells. The early events in
this process have been investigated here. The induction of p53
expression correlates with a cell cycle arrest in the G1 and G2/M
phases of the cell cycle within 24 h of exposure. The molecular
mechanism governing the decreased proliferation appears to
involve the induction of the cyclin dependent kinase (cdk)
inhibitor p21CIP1 and its functional association with cdk2.
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1. Introduction
The p53 protein is intimately involved in the response of
mammalian cells to genotoxic stresses, including gamma irra-
diation [1^3]. The activation of p53 is achieved by a variety of
mechanisms including changes to the half-life of the protein,
increased translation of p53 and altered post-translational
modi¢cation (reviewed in [1]). Once p53 is activated, it is
involved in a number of di¡erent cellular processes including
cell cycle arrest, DNA repair and apoptosis [2,3]. Some of
these functions can be accounted for by the transcriptional
activity of p53; several cell genes are induced following p53
activation including p21CIP1, mdm-2, gadd45, cyclin G, bax
and IGF-BP3 [2]. However, the identi¢cation of a point mu-
tation in the p53 gene that renders p53 transcriptionally in-
active yet still promotes apoptosis demonstrates that p53 must
also act via non-transcriptional routes [4].
We and others have observed that the expression of p53 is
increased following the infection of primary human B-cells
with the DNA tumour virus Epstein-Barr virus (EBV) [5,6].
The activation is manifested by an increase in the expression
of p53 RNA and protein in infected cells [5] and an increase in
the expression of the p53 responsive gene p21CIP1 [7]. It has
been suggested that this is achieved via the activation of the
transcription factor NFUB by two EBV genes, EBNA-2 and
LMP-1 [8]. The increased expression of p53 following infec-
tion of quiescent primary B-cells with EBV was a surprising
observation since EBV causes cells to enter into the cell divi-
sion cycle and to proliferate inde¢nitely, resulting in the gen-
eration of immortal lymphoblastoid cell lines (LCLs) (re-
viewed in [9]). Thus, in the context of EBV infected B-cells,
the elevated levels of p53 did not appear to be su⁄cient to
activate either its cell cycle arrest or apoptosis programmes.
This leads to the hypothesis that the activation of the cell
proliferation pathway by EBV primes infected cells to respond
to any subsequent genotoxic stress by inducing the expression
of basal levels of p53 and p21CIP1. Consistent with this, we
have shown that the level of p21CIP1 in LCLs remains below
the threshold required to fully inhibit the activity of the cyclin
dependent kinase, cdk2 [7], and we and others have shown
that p53 levels are elevated still further in LCLs after exposure
to genotoxic agents [5,10^14].
In this report, we characterise the downstream e¡ects of the
exposure of LCLs to the genotoxic agent gamma irradiation.
Early in the response, increased expression of p53 and p21CIP1
were observed. This correlates with an association of p21CIP1
with cdk2 and an inhibition of cdk2 associated histone H1
kinase activity. Cell cycle arrest is observed within 24 h of
the exposure, which involves cell cycle checkpoints in the
G1, G2/M and possibly also S phases. This contrasts with
the predominant outcome for LCLs exposed to another geno-
toxic agent, cisplatin, and to LCLs which are subject to the
enforced expression of p53; in both of these situations, cell
cycle arrest and apoptosis occur almost simultaneously within
24 h [5].
2. Materials and methods
2.1. Cell culture
Lymphoblastoid cell lines, IB4 [15] and LCL#3 [16], were main-
tained at a density of between 2 and 8U105/ml in standard growth
medium [16].
The viability of the cells was determined using a trypan blue ex-
clusion assay [17].
2.2. DNA synthesis assay
2U105 LCL cells, in 1 ml of standard culture medium, were incu-
bated with 1 WCi of [3H]thymidine for 2 h. After washing in PBS, the
cells were lysed in 1 ml of 10% (w/v) trichloroacetic acid (TCA) and
the precipitated material collected onto a GF/C (Whatman) ¢lter.
Following extensive washing with 10% (w/v) TCA, the ¢lters were
allowed to air dry. The [3H]thymidine incorporation into acid insolu-
ble material was determined by liquid scintillation counting. All ex-
periments were performed in triplicate.
2.3. Western blot analysis
Cells were harvested and washed with PBS. Total protein extracts
were prepared from the LCLs and fractionated on SDS-polyacryl-
amide gels as described previously [7]. Proteins were transferred to
either nitrocellulose membrane or PVDF membrane by Western blot-
ting and blocked with a 5% (w/v) solution of skimmed milk powder in
PBS supplemented with 0.1% (v/v) NP40. The primary antibodies
were diluted in the same bu¡er and incubated with the ¢lters for
between 1 and 24 h at 4‡C. Primary antibodies included: anti-
PARP (Boehringer Mannheim); anti p53 (DO1, [18]); anti-p21CIP1
[19] ; and cdk2 (M2, Santa Cruz). This was followed by extensive
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washing in PBS supplemented with 0.1% (v/v) NP40. To detect p21
and p53, a species speci¢c secondary antibody (DAKO) was applied
for 1 h at room temperature. Following a washing step, HRP-con-
jugated species speci¢c secondary antibodies (Amersham or DAKO)
were applied to the ¢lters and incubated for 1 h at room temperature.
Following further washing, an enhanced chemiluminescence (ECL)
reaction was undertaken (Amersham) and the resulting signals were
recorded by autoradiography.
2.4. Kinase assays
NP40 extracts were prepared by lysing the 1U107 cells/ml on ice in
150 mM NaCl, 50 mM HEPES, pH 7.5, 1 mM EDTA, 1 mM DTT,
0.1% (v/v) NP40, 10% (v/v) glycerol, 0.1 mM PMSF, 2 Wg/ml aproti-
nin, 1 mM sodium £uoride, 0.1 mM sodium orthovanadate, 10 mM L-
glycerophosphate. Following a brief exposure to sonication (2 min),
the lysates were clari¢ed by centrifugation at 12 000 rpm in a micro-
fuge and endogenous immunoglobulins collected by incubation with
protein G-Sepharose beads. Antibodies were then added to the pre-
cleared supernatant for 120 min at 4‡C. The antibody-protein com-
plexes were collected on protein G-Sepharose beads for a further
30 min at 4‡C. The complexes were washed 4 times in lysis bu¡er
followed by 2 washes in 50 mM HEPES, pH 7.5, 1 mM DTT. The
complexes were then incubated in 40 Wl of kinase bu¡er [7] contain-
ing 1 Wg of histone H1 (Boehringer Mannheim) and 10 WCi of [Q-
32P]ATP. Following a 30-min incubation at 30‡C, the samples were
heated to 95‡C in the presence of total protein extraction bu¡er [7]
and the proteins separated on SDS-polyacrylamide gels. The gels
were ¢xed by incubation in 10% (v/v) ethanol, 10% (v/v) acetic
acid, dried and phosphorylated proteins identi¢ed by autoradiogra-
phy.
2.5. Complex assays
NP40 extracts were prepared and proteins precipitated as described
for cdk2 kinase assays. The complexes were heated to 95‡C in the
presence of total protein extraction bu¡er and the proteins separated
on a 15% SDS-polyacrylamide gel. Following Western blotting to
nitrocellulose membrane, the ¢lter was incubated with anti-p21CIP1
antisera [19] and signals detected by ECL.
2.6. FACs analysis
Cells were harvested, washed with PBS and ¢xed in 65% (v/v) etha-
nol at 4‡C for at least 24 h. The cells were then incubated in 0.1% (v/
v) Triton X-100, 3.7% (w/v) EDTA, 100 Wg/ml propidium iodide, 6
Wg/ml RNaseA for 30 min in the dark. The DNA content of the cells
was analysed using a Coulter Epics £uorescence activated cell sorter
(FACs). Human mononuclear lymphocytes were used to identify the
peak of 2n DNA content. Gates were manually applied to the 2n, 4n
and 2^4n populations of cells.
FEBS 21145 20-11-98
Fig. 1. The proliferation of LCLs is compromised by exposure to gamma irradiation. Exponentially growing LCLs were exposed to 6 Gy of
gamma irradiation where indicated. The cells were then seeded at a density of 20U104/ml. A: After 48 h the number of viable cells were deter-
mined. The error bars represent the S.E.M. from 3 experiments. B: After 4 and 48 h, total protein extracts were prepared from the cells, frac-
tionated on a 10% SDS-polyacrylamide gel, blotted onto PVDF membrane and exposed to anti-PARP antisera. The resulting signal was de-
tected using ECL. The migration of the molecular weight standards (in kDa), full length PARP and the larger of the PARP-cleavage products
are indicated. C: After 24 h LCL#3 cells were harvested and ¢xed. Subsequently, the cells were stained with propidium iodide and the DNA
content analysed by FACs using a Coulter Epics £ow cytometer. The DNA pro¢le is shown in the upper panel with the analysis of the % of
cells in particular phases of the cell cycle below. D: At the indicated times (in hours) the rate of DNA synthesis in LCL#3 cells was deter-
mined. [3H]Thymidine was included for the ¢nal 2 h of each incubation. The [3H]thymidine incorporation into acid insoluble material was de-
termined in triplicate and the S.E.M. is represented as error bars.
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3. Results and discussion
We characterised the response of two LCLs, LCL#3 and
IB4, to 6 Gy (600 Rads) of gamma irradiation. Within 48 h,
clear di¡erences in the number of viable cells in the non-ex-
posed compared to the exposed populations were apparent
(Fig. 1A). This suggests that the exposure to gamma irradi-
ation either initiated an arrest in cell proliferation or an in-
crease in apoptosis. To distinguish between these possibilities,
we asked whether we could detect evidence for apoptosis in
these cells. An early event during apoptosis is the activation of
ICE-like proteases, which speci¢cally cleave the 113-kDa pol-
y(ADP)ribose polymerase (PARP) protein generating two sta-
ble products of lower molecular weight. Since we were unable
to detect either of these products during the ¢rst 48 h post-
exposure (Fig. 1B), we suggest that an arrest of cell prolifer-
ation is the most likely outcome for cells at this stage. Sup-
porting evidence that an arrest of proliferation predominates
over apoptosis came from the analysis of changes to the rate
of DNA synthesis and from the pro¢le of the DNA content of
LCL#3 cells 24 h after exposure. Fig. 1C demonstrates that
exposed cells are present in the G1 and G2/M phases of the
cell cycle. Concomitant measurements of the rate of DNA
synthesis (Fig. 1D) show a 14-fold decrease suggesting that
the G1 and the G2/M cells are arrested. This, together with
the paucity of cells in the apoptotic window with a sub-G1
DNA content, allows us to conclude that the predominant
early response to gamma irradiation exposure in LCLs is
the activation of G1 and G2/M cell cycle check points.
In order to address the molecular mechanism by which this
cell cycle arrest occurs, we investigated whether the expression
of p53 and p21CIP1 were a¡ected. Both p53 and p21CIP1 were
elevated within 2 h in LCL#3 cells after exposure (Fig. 2).
This con¢rms and extends previous investigations that dem-
onstrate that the induction of p53 and p21CIP1 are apparent
within 4^6 h [10^14]. The timing of the induction of p53 and
p21CIP1 is consistent with a model suggesting that the induc-
tion of transcriptionally active p53, in response to DNA dam-
age, activates the expression of p21CIP1. However, the key
question is whether the level of p21CIP1 within the exposed
cells has been raised above the threshold required to inhibit
cyclin dependent kinases (cdks).
The association of cdk2 with p21CIP1 was investigated in
irradiated and non-irradiated LCL#3 cells. The overall level
of cdk2 expression was not signi¢cantly altered following ex-
posure to gamma irradiation (Fig. 3A). However, the amount
of p21CIP1 associated with cdk2 was dramatically increased
(Fig. 3B, track 1 compared with track 2). We then assessed
the functional signi¢cance of the p21CIP1 association with
cdk2 by comparing the kinase activity of cdk2 containing
complexes, before and after exposure to gamma irradiation.
As seen in Fig. 4, no activity was seen when mock complex
isolations were undertaken. In contrast to this, when the cdk2
antibody was used in the absence of exposure a basal level of
kinase activity directed against histone H1 was observed. Sur-
prisingly, a reproducible increase in the cdk2 activity was
observed after 7^8 h. This was likely to be a response to the
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Fig. 2. Steady state levels of p53 and p21 are rapidly elevated.
LCL#3 cells, were exposed to 6 Gy of gamma irradiation (3/+). At
the indicated times (in hours) total protein extracts were prepared
from the cells, fractionated on a 10% (upper panel) or a 15% (lower
panel) SDS-polyacrylamide gel, blotted onto nitrocellulose mem-
brane and exposed to anti-p53 or anti-p21 antisera. The resulting
signals were detected using ECL. The migration of the molecular
weight standards (in kDa) and the proteins of interest are shown.
Fig. 3. The level of expression of cdk2 is unaltered, but its associa-
tion with p21CIP1 increases. LCL#3 cells were exposed to 6 Gy of
gamma irradiation (3/+). A: At the indicated times (in hours) total
protein extracts were prepared and fractionated on a 15% SDS-
polyacrylamide gel, blotted onto nitrocellulose membrane and ex-
posed to anti-cdk2 antisera. The resulting signal was detected using
ECL. B: After 4 h NP40 extracts were prepared from the cells.
Cdk2 and associated proteins were puri¢ed by immunoprecipitation
(+). In parallel, mock precipitations were carried out using control
sera (3). The resulting proteins were fractionated on a 15% SDS-
polyacrylamide gel, blotted onto nitrocellulose membrane and ex-
posed to anti-p21 antisera. The resulting signal was detected using
ECL. The migration of the molecular weight standards (in kDa) is
shown.
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stimulation the cells received after dilution into fresh medium
at the start of the experiment, potentially involving changes in
cyclin/cdk expression or cdk phosphorylation. Despite this,
within 4 h from the exposure, a signi¢cant reduction in
cdk2 associated kinase activity was observed. A similar reduc-
tion was observed when retinoblastoma protein is used as the
substrate for the in vitro kinase assay (data not shown).
In this report, we characterise the downstream e¡ects of the
exposure of LCLs to the genotoxic agent gamma irradiation.
In agreement with previous investigations, it is apparent that
the major early response of EBV immortalised cells is cell
cycle arrest ([10^14,20] and Fig. 1). We con¢rm the observa-
tion that the expression of both p53 and the p53-responsive
gene p21CIP1 are induced above their basal levels following
irradiation [10^14]. We show that these are early events,
reaching maximal levels by 15 min post-exposure and being
maintained at this level for at least 8 h (Fig. 2). Furthermore,
we investigate the biochemical consequences of the increase in
p21CIP1 protein following irradiation. A dramatic decrease in
cdk2 associated kinase activity is detected within 4 h of ex-
posure, in the absence of changes to the basal level of expres-
sion of cdk2 (Figs. 3 and 4). This correlates temporally with
the formation of complexes containing both cdk2 and the
inhibitor p21CIP1 (Fig. 4). Thus in EBV immortalised LCLs,
at the basal (EBV induced) level of expression, p21CIP1 does
not prevent the formation of active cdk2 containing kinase
complexes, whereas, following exposure to gamma irradiation,
the induced p21CIP1 associates with cdk2 in an inhibitory
manner. This is consistent with current models describing
the e¡ects of elevated p53 and p21CIP1 levels in other cell types
[1^3]. In addition, since the p53 induced pathway appears
to be fully functional in LCLs, this provides further support
for the conclusion that the viral genes expressed in EBV
immortalised LCLs do not disrupt the function of p53
[5,7,21].
However, it is interesting to note that the outcome of the
enhanced expression of p53 in LCLs does not always follow
the course detailed here. Indeed, the exposure of LCLs to
another genotoxic agent, cisplatin, causes a rapid G1 cell cycle
arrest combined with almost simultaneous apoptosis, resulting
in the survival of few viable cells 24 h after the initial exposure
[5]. Although some apoptosis is observed in LCLs between 24
and 72 h after exposure to gamma irradiation (20^30% of the
population of cells) [13,14], the early responses to these two
genotoxic agents are clearly distinct. The alternate responses
of LCLs to gamma irradiation and cisplatin may be a re£ec-
tion of the biochemical responses induced by the di¡erences in
DNA damage: gamma irradiation causes double-strand DNA
breaks whereas cisplatin generates intra- and inter-strand
crosslinks. However, the combined cell cycle arrest/apoptosis
response, which is characteristic of cisplatin treated cells, ap-
pears to be mediated solely by the elevated levels of p53, since
enforced expression of p53 in LCLs and some Burkitt’s lym-
phoma cell lines stimulates the same outcome [5,22,23].
Since the experiments investigating gamma irradiation ex-
posure, enforced p53 expression and cisplatin exposure have
been undertaken in the same cell line (IB4), we can exclude
the possibility that the genetic background of the cell directs
the alternate outcomes. Therefore, we propose that one of the
following scenarios accounts for the di¡erence in the decision
to instigate the cell cycle arrest or the cell cycle arrest plus
apoptosis programmes. (i) The absolute level of expression of
p53 within the cells may govern which branches of the p53
response pathway are activated, with cell cycle arrest being
triggered by more modest changes in expression than apopto-
sis. (ii) Additional molecular changes in the gamma irradiated
cells may modulate the function of the p53 initiated apoptosis
pathway while allowing the p53 initiated cell cycle arrest path-
way to proceed. Since the timing and degree of p53 induction
are similar (Fig. 2, [5] and data not shown), the latter scenario
is more likely.
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